Dementia Discovery Fund
Overview
The Dementia Discovery Fund is a close collaboration between charity, industry and the government, to provide much-needed investment in innovative dementia research. The fund is specifically for businesses that are developing medicines and therapies for the treatment of dementia and related illnesses.
Investment Focus
- Companies developing novel therapeutics for dementia
- Early-stage biotech companies
- Innovative approaches to dementia treatment
Portfolio Companies
Reach Dementia Discovery Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Dementia Discovery Fund
What sectors does Dementia Discovery Fund invest in?
Dementia Discovery Fund invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in London, United Kingdom. Dementia Discovery Fund is listed as a vc in the ConnectSafely investor database.
What stage does Dementia Discovery Fund invest at?
Dementia Discovery Fund backs companies at Pre-Seed, Seed, Series A and Series B, writing cheques of 3M - 10M.
Which regions does Dementia Discovery Fund invest in?
Dementia Discovery Fund invests across United States, United Kingdom and Europe.
Who are the partners at Dementia Discovery Fund?
Team members listed for Dementia Discovery Fund include Laurence Barker (Partner at SV Health Investors) and Miles Gerson (Partner at SV Health Investors).
What companies has Dementia Discovery Fund invested in?
Dementia Discovery Fund's portfolio includes Therini Bio, Cerevance and Caraway Therapeutics.
How do I contact Dementia Discovery Fund?
Dementia Discovery Fund's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
